Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.250
0.00 (0.00%)
Mar 10, 2026, 10:39 AM AEST

ASX:PAR Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
11011989279224483
Upgrade
Market Cap Growth
-50.96%32.94%-67.97%24.43%-53.57%-31.80%
Upgrade
Enterprise Value
1049456195170398
Upgrade
Last Close Price
0.250.300.260.960.932.03
Upgrade
PS Ratio
12995.69---2829.6423494.01
Upgrade
PB Ratio
18.315.613.605.205.306.17
Upgrade
P/TBV Ratio
21.575.724.095.505.706.41
Upgrade
EV/Sales Ratio
----2142.5319352.81
Upgrade
Debt / Equity Ratio
1.5600.010.010.020.01
Upgrade
Net Debt / Equity Ratio
-0.89-0.79-0.71-1.04-0.92-0.90
Upgrade
Net Debt / EBITDA Ratio
0.140.730.270.940.821.63
Upgrade
Net Debt / FCF Ratio
0.201.050.271.241.212.01
Upgrade
Asset Turnover
0---0.000
Upgrade
Quick Ratio
1.277.177.124.855.9313.74
Upgrade
Current Ratio
1.317.467.514.896.0213.98
Upgrade
Return on Equity (ROE)
-180.22%-81.66%-149.69%-108.16%-65.10%-36.79%
Upgrade
Return on Assets (ROA)
-82.94%-55.11%-85.28%-63.78%-44.22%-27.38%
Upgrade
Return on Capital Employed (ROCE)
-592.70%-109.40%-260.30%-111.20%-111.80%-54.70%
Upgrade
Earnings Yield
-32.87%-15.80%-65.74%-18.61%-17.51%-7.10%
Upgrade
FCF Yield
--13.46%-73.81%-16.20%-14.37%-7.24%
Upgrade
Buyback Yield / Dilution
-7.48%-7.23%-17.43%-7.34%-1.21%-14.32%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.